Meves Pharmaceuticals, Inc. — Form D
Meves Pharmaceuticals, Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2018-03-29. The offering totals $30.9M, of which $10.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-03-29
- Form: D
- Accession: 0001735555-18-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $30.9M
- Amount sold: $10.9M
- Remaining: $20.0M
- Investors: 4
- Date of first sale: 2018-03-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-308878
Issuer
- Name: Meves Pharmaceuticals, Inc.
- CIK: 0001735555
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 57 West 57th St., New York, NY, 10019
- Phone: 510-375-1669
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Ben Auspitz | Director | Cambridge, MA |
| Peter Barber | Director | New York, NY |
| Joshua Grass | Director | San Diego, CA |
| Rishi Gupta | Director | New York, NY |
| Joshua Grass | Executive Officer | San Diego, CA |
More